Singapore, Sept. 1 -- TAKEDA PHARMACEUTICAL COMPANY LIMITED made the following announcement:
Security Name: NA
General Announcement::U.S. Food and Drug Administration approval of the New Drug Application for MIMRYLO (rusfertide) (https://links.sgx.com/1.0.0/corporate-announcements/X19ABHX1PFFLNM9Y/8c7534dc33f5effbdf1449ec769dbdebd774a8b735d2367dd166924e8ddf2b9c)
Published by HT Digital Content Services with permission from South East Asian News....